Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review
Introduction: Olanzapine (OLZ) is a second generation antipsychotic that is approved for the treatment of schizophrenia, bipolar disorder type 1 as monotherapy (acute manic or mixed episodes, maintenance), or as an add-on to lithium or valproate (manic or mixed episodes). It is one of the most effec...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Association of Psychiatric Pharmacists
2023-08-01
|
| シリーズ: | Mental Health Clinician |
| 主題: | |
| オンライン･アクセス: | https://theijpt.org/doi/pdf/10.9740/mhc.2022.08.254 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|